Barely Significant
← all phrases

“a decreasing trend”

47,181 sentences · 47,181 papers · 78,848 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

The detection rate of cytologically malignant nodules among all participants was 0.039% for the first-round survey, 0.026% for the second-round survey, and 0.015% for the third-round survey, with a decreasing trend as the number of examinations increased (Table 4 ). 18 Age-dependent increases in the detection rate of cytologically malignant nodules were observed in all rounds of surveys. 18 The incidence rate of cytologically diagnosed thyroid cancer in the second-round survey in each age group was calculated from the intervals between the two examinations for participants who had undergone both the first- and second-round surveys. 19 This study also showed an increase in the incidence rate of cytologically malignant nodules in parallel with the age at examination.
However, while efforts should be made to increase response rates in future studies of self-overestimation of compliance, there is also a decreasing trend of response rates among surgical doctors [ 35 ], and the response rate in the present survey at least falls within one standard deviation of the average rate reported in 2019.
The ACEF II score was defined as age/ejection fraction + 1 (serum creatinine > 2.0 mg/dL) + 3 (emergency surgery) + 0.2 × (36%-hematocrit).Dialysis was defined as the appearance of indications that included uremia (eGFR < 10 ml/min, creatinine > 707 μmol/L), hyperkalemia (serum potassium > 5.5 mmol/L), acidosis (decreased plasma [HCO − ], or increased plasma [H 2 CO 3 ] concentration, or pH showed a decreasing trend), volume overload (renal insufficiency accompanied by obvious edema, pulmonary edema, and cardiac insufficiency) [ 28 ], or biochemical abnormalities (such as endogenous creatinine clearance rate < 10 mL/min, urea nitrogen > 28.6 mmol/L, or blood creatinine > 707 μmol/L), due to renal insufficiency and were based on clinical judgment by the nephrologist,cardiac surgeon and ICU consultant.and they also participated in dialysis strategy.
cristatum showed a decreasing trend, such as Ginsenoside Ra1, Vinaginsenoside R16, Vinaginsenoside R3, Ginsenoside C, Ginsenoside Re, Ginsenoside Rg5, Ginsenoside F2, Ginsenoside B2, Vinaginsenoside R17, Ginsenoside Rh3, Tragopogonsaponin B, Ginsenoside Mc, Cynarasaponin C and Ginsenoside Rf.